Objective Increasing evidence suggests that cancer-associated inflammation is associated
with poor prognosis in patients with cancer. The role of the neutrophil–lymphocyte ratio …

Background Inflammation plays a crucial role in cancer development. In this study, we
evaluate the prognostic values of systemic inflammation markers such as neutrophil-to …

Background Previous prognostic models for second-line systemic therapy in patients with
metastatic renal cell carcinoma have not been studied in the setting of targeted therapy. We …

Abstract Treatment with chimeric antigen receptor-modified T cell (CAR-T) has demonstrated
promising therapeutic efficacy in hematologic malignancies. However, the therapeutic …

Background To investigate the association between pretreatment blood neutrophil-to-
lymphocyte ratio (NLR) and clinical outcomes for advanced-stage cancer patients treated …

Aim: Estimate prognosis and clinical outcome of patients with localized or metastatic renal
cell carcinoma (RCC) is an important issue which drive our medical decisions. Methods: We …

The relationship between inflammation and tumor development and progression has been
recognized in recent decades. NLR is an easily reproducible and widely used inflammatory …

Background: The present study aimed to investigate the utility and importance of the various
parameters of complete blood count panel for benign-malignant differentiation of adnexal …

Background: The study aimed to evaluate changes in hematologic parameters, including
white blood cell, platelet count, platelet indices, the platelet to lymphocyte and neutrophil to …

Background: Although many prognostic factors have been identified for lung cancers, new
ones are needed to determine the course of the disease. Recently, a high neutrophil to …